跳至主要内容
临床试验/JPRN-UMIN000053134
JPRN-UMIN000053134尚未招募Unknown

A multicenter retrospective study to evaluate the efficacy and safety of platinum-based chemotherapy in combination with immunotherapy for extensive-stage small cell lung cancer in the real-world setting - Efficacy and safety of combination-immunotherapy for ES-SCLC

Shinshu University0 个研究点目标入组 350 人开始时间: 2024年1月20日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
350

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 120years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who are judged by the attending doctor as inappropriate to participate in this clinical research

研究者

相似试验